title: Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review.
abstract: Determination of the respiratory tract deposition of airborne particles is critical for risk assessment of air pollution, inhaled drug delivery, and understanding of respiratory disease. With the advent of nanotechnology, there has been an increasing interest in the measurement of pulmonary deposition of nanoparticles because of their unique properties in inhalation toxicology and medicine. Over the last century, around 50 studies have presented experimental data on lung deposition of nanoparticles (typical diameter≤100 nm, but here≤300 nm). These data show a considerable variability, partly due to differences in the applied methodologies. In this study, we review the experimental techniques for measuring respiratory tract deposition of nano-sized particles, analyze critical experimental design aspects causing measurement uncertainties, and suggest methodologies for future studies. It is shown that, although particle detection techniques have developed with time, the overall methodology in respiratory tract deposition experiments has not seen similar progress. Available experience from previous research has often not been incorporated, and some methodological design aspects that were overlooked in 30-70% of all studies may have biased the experimental data. This has contributed to a significant uncertainty on the absolute value of the lung deposition fraction of nanoparticles. We estimate the impact of the design aspects on obtained data, discuss solutions to minimize errors, and highlight gaps in the available experimental set of data.
authors.affiliation: 1 Ergonomics and Aerosol Technology (EAT), Lund University , SE-221 00 Lund, Sweden .
authors.forename: Jakob
authors.initials: J
authors.lastname: Löndahl
authors.forename: Winfried
authors.initials: W
authors.lastname: Möller
authors.forename: Joakim H
authors.initials: JH
authors.lastname: Pagels
authors.forename: Wolfgang G
authors.initials: WG
authors.lastname: Kreyling
authors.forename: Erik
authors.initials: E
authors.lastname: Swietlicki
authors.forename: Otmar
authors.initials: O
authors.lastname: Schmid
mesh_terms: D000280:Administration, Inhalation; D000336:Aerosols; D000818:Animals; D002626:Chemistry, Pharmaceutical; D004058:Diffusion; D006801:Humans; D001239:Inhalation; D019570:Inhalation Exposure / Q000009:adverse effects*; D008168:Lung / Q000033:anatomy & histology / Q000502:physiology*; D008953:Models, Anatomic; D053758:Nanoparticles; D010316:Particle Size; D052638:Particulate Matter / Q000009:adverse effects*; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000737:chemistry; D018570:Risk Assessment
chemical_list: D000336:Aerosols; D052638:Particulate Matter; D004364:Pharmaceutical Preparations
keywords: NSAM; aerosol; dosimetry; engineered nanoparticles; health; inhalation; lung deposition; pulmonary; ultrafine particles